CEACAM3 抗体 (AA 177-226)
(4 references)Quick Overview for CEACAM3 抗体 (AA 177-226) (ABIN6746759)
抗原
See all CEACAM3 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 177-226
-
特异性
- Human CEACAM3
-
预测反应
- Percent identity by BLAST analysis:
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide located between aa177-226 of human CEACAM3 (P40198, NP_001806). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla (100%).
Type of Immunogen: Synthetic peptide
-
-
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3) (AA 35-155) antibody
CEACAM3 适用: 人, 大鼠 WB, ELISA, FACS 宿主: 小鼠 Monoclonal 8D5F12 unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3) antibodyCEACAM3 适用: 人, 小鼠 IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3) (AA 1-135) antibodyCEACAM3 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3) (AA 1-135) antibodyCEACAM3 适用: 人 IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3) (AA 273-416) antibodyCEACAM3 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3) (AA 163-191), (C-Term) antibodyCEACAM3 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal RB33877 unconjugated
-
-
应用备注
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
: "Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 16, pp. 10364-9, (2002) (PubMed).
: "Caspase activation involves the formation of the aposome, a large (approximately 700 kDa) caspase-activating complex." in: The Journal of biological chemistry, Vol. 274, Issue 32, pp. 22686-92, (1999) (PubMed).
: "Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis." in: The EMBO journal, Vol. 18, Issue 13, pp. 3586-95, (1999) (PubMed).
: "Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition." in: Science (New York, N.Y.), Vol. 284, Issue 5411, pp. 156-9, (1999) (PubMed).
-
: "Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 16, pp. 10364-9, (2002) (PubMed).
-
-
